accountRESEARCH TRIANGLE PARK – Four years ago, Cerberus Capital Managment chief Stephen Feinberg and Ampersand Ventures made a $590 million bet on Talecris Biotherapeutics. Looks like from here on, they will be playing with house money. That $590 million...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to $600M Talecris stake worth $2 billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account